Metabolic alkalosis
ICD-10 E87.3 · ICD-11 5C74

Treatment of Metabolic Alkalosis with Hypercalcemia and Intravascular Volume Depletion

This protocol covers the management of metabolic alkalosis when it occurs together with hypercalcemia, intravascular volume depletion, and decreased kidney function — a presentation consistent with calcium-alkali (milk-alkali) syndrome.

Clinical scenario

The combination of PTH-independent hypercalcemia, metabolic alkalosis, and impaired kidney function defines this syndrome. Intravascular volume depletion is a central feature and determines the therapeutic priority — it must be addressed before other interventions are considered.

Initial approach

Aggressive volume expansion with isotonic saline is the most important initial therapeutic maneuver in this setting. Therapies that may be used for hypercalcemia in other clinical contexts are not the first choice here — the full decision algorithm is in the complete protocol.

Complete regimen, sequencing, and additional interventions are available in the structured protocol.

Treatment goals

Decrease in serum calcium and improvement of mental status within 24 hours of starting treatment.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1053/j.ajkd.2021.12.016
View source ↗